However, despite its advantages, the MELD score incorrectly predicts mortality in about 15–20% of patients due to the score not including major cirrhotic complications such as bleeding, bacterial infection, HE, and albumin levels, which induce a poor prognosis for patients [9]. This evidence concerns the gene ALB and bacterial infectious disease.